Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

Private equity firm Apiary Capital has completed its investment into life sciences performance marketing and specialist ...

BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...

Inizio Evoke has appointed Tristen George and Kevin Kaniuga as executive creative directors in a move aimed at “further strengthening” the agency’s creative leadership. George and Kaniuga both hold ...

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their HER2-directed antibody drug ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

The Weber Shandwick Collective (TWSC) has announced the appointment of Lucie Harper as president of Health, UK. Harper brings ...

Eli Lilly will be licensing Alchemab Therapeutics’ preclinical programme for amyotrophic lateral sclerosis (ALS) and other ...

One of the most critical topics to address in health care today is the mental health and well-being of physicians and other ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...